Abstract
Recent study indicates that the binding of caveolin-1 (CAV1), the essential constituent of caveolae, to endothelial nitric oxide synthase (eNOS) prevents nitric oxide (NO) production in cirrhotic human liver. However, their interplay in hepatocellular carcinoma (HCC) remains undetermined. Paraffin-embedded sections from 73 HCC patients were included in this study. The expression patterns of CAV1 and eNOS determined by immunohistochemistry were correlated with the clinicopathological characteristics and overall survival. Although CAV1 expression did not correlate with any clinicopathological characteristic, increased CAV1 expression was associated with prolonged overall survival (p = 0.021), even when using the multivariate Cox's regression model (OR = 0.25, 95%CI = 0.08-0.72, p = 0.011). eNOS expression was correlated with an increased histological grade (p = 0.002) and intriguingly, the patients had a decreased overall survival when their lesions presented with high eNOS but low CAV1 expression concomitantly (p = 0.003). Meanwhile, the increased CAV1/eNOS merged level determined by immunofluorescence was significantly associated with a decreased histological grade and better overall survival (p = 0.023 and 0.001, respectively)...Continue Reading
References
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·S J LeibovichA E Koch
Nov 1, 1994·The Journal of Clinical Investigation·M ZicheF Ledda
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·D C JenkinsS Moncada
Nov 1, 1996·Journal of Viral Hepatitis·P J ScheuerA P Dhillon
Mar 2, 1999·Developmental Biology·S S YuanE Y Lee
Jun 26, 2001·Liver·H YokomoriH Ishii
May 25, 2002·Liver·Hiroaki YokomoriHiromasa Ishii
Sep 27, 2003·Acta Physiologica Scandinavica·W ZhangB C Kone
Oct 18, 2003·Journal of Gastroenterology·Hiroaki YokomoriHiromasa Ishii
Apr 20, 2004·The Journal of Pathology·Harriet WikmanSisko Anttila
Sep 10, 2004·The Journal of Biological Chemistry·Terence M WilliamsMichael P Lisanti
Sep 24, 2004·Physiological Reviews·Alex W CohenMichael P Lisanti
Oct 13, 2004·Mutation Research·Chinthalapally V Rao
Oct 20, 2004·Circulation·Paul B MassionJean-Luc Balligand
Jul 16, 2005·Biochimica Et Biophysica Acta·Soazig Le Lay, Teymuras V Kurzchalia
Oct 11, 2005·Biochimica Et Biophysica Acta·Radu V Stan
Oct 26, 2005·Breast Cancer Research and Treatment·Gert G Van den EyndenKenneth L van Golen
Jan 18, 2006·Cardiovascular Research·Carsten SchwenckeRuth H Strasser
Mar 28, 2006·Journal of Clinical Pathology·S-N WangK-T Lee
Apr 18, 2006·Atherosclerosis·Constanze MeyePeter Gross
Jun 2, 2006·The British Journal of Surgery·S-N WangK-T Lee
Aug 12, 2006·Journal of Clinical Pathology·Sheau-Fang YangKing-Teh Lee
Feb 23, 2007·Cell Cycle·Philippe G Frank, Michael P Lisanti
Feb 24, 2007·Nature Reviews. Molecular Cell Biology·Robert G Parton, Kai Simons
Aug 30, 2008·The American Journal of Pathology·Ningling Kang DeckerVijay H Shah
Citations
Jan 19, 2013·Cell Death & Disease·C MeyerS Dooley
Jan 24, 2013·Cell Communication and Signaling : CCS·Christoph MeyerSteven Dooley
Jan 24, 2014·PloS One·Xiaohong GaiXin Zheng
Aug 26, 2014·PloS One·Peyda KorhanNeşe Atabey
Sep 26, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Ye ZhangYun-peng Liu
Nov 15, 2011·Annual Review of Pathology·Federica SotgiaMichael P Lisanti
Jul 25, 2015·Clinics and Research in Hepatology and Gastroenterology·Wei-Ren LiuYing-Hong Shi
Sep 3, 2014·PloS One·Hongxiu YuPengyuan Yang
Jun 14, 2018·Cancer Science·Makoto TakedaHiroya Takeuchi
May 27, 2017·Oxidative Medicine and Cellular Longevity·Shengqi WangZhiyu Wang
Sep 22, 2015·Oncotarget·Chih-Jen YangYao-Tsung Yeh
Nov 18, 2016·Molecular Cancer·Zeribe Chike NwosuChristoph Meyer
Dec 13, 2019·Ultrastructural Pathology·Iuliia TaskaevaIzabella Gogaeva
Jun 1, 2017·World Journal of Surgery·Blanca TorrejónJesús García-Foncillas
Jun 29, 2021·Frontiers in Cell and Developmental Biology·Maoyu LiYongheng Chen